16 February 2026
Verovaccines Positions for Growth: Management Transition to Accelerate Value Creation
- Prof. Dr. Sven-Erik Behrens will transition to the Board of Directors
- Dr. Ulrike Diesterbeck DVM assumes the role of Managing Director
- Positioning the company for intensified product development and improved market access